You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

À propos des lignes directrices

Displaying Guidelines

20 articles

Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

Document Status: Current
ID: 2-29
Version: 4

Feb 2024

An Endorsement of the 2021 Cancer Care Alberta Clinical Practice Guideline on Uveal Melanoma

Document Status: Current
ID: C50-CIDAP-1

Mar 2024

An Endorsement of the 2023 European Association of Urology (EAU) -American Society of Clinical Oncology (ASCO) Guidelines on Penile Cancer

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-2

Updated

Nov 2024

An Endorsement of the ASTRO/ESTRO 2023 Guideline for the Treatment of Patients with Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

Document Status: Current
ID: GL END 7-24

Updated

Nov 2024

Comparison of PET/CT and PET/MR Imaging in Oncology

Document Status: Current
ID: ES PET 16
Version: 2

Apr 2024

Consensus Diagnostic and Prognostic Testing for Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: Recommendations Report - 2024

Document Status: Current
Version: 1.0

Jan 2024

Endometrial Cancer Molecular Testing Recommendations Report

Document Status: Current
Version: 1

Updated

Nov 2024

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2023

Document Status: Current
Version: PET 2023-2

Jun 2024

Exercise for People with Cancer

Document Status: Current
ID: 19-5
Version: 2

Jul 2024

Fear of Cancer Recurrence Guideline

Document Status: Current
ID: GL 19-7

Mar 2024

First-line treatment of advanced-stage Hodgkin lymphoma

Document Status: Current
ID: ES 6-25

Oct 2024

Follow-up and Surveillance of Curatively Treated Lung Cancer Patients

Document Status: Current
ID: 26-3
Version: 2

Feb 2024